To various degrees, psychopharmacologic medications are associated with side effects. Despite improvements in newer psychopharmacologic medication, monitoring for side effects remains important for individuals with mental retardation and developmental disabilities for a number of reasons, of which p
Nutritional, dietary, and hormonal treatments for individuals with mental retardation and developmental disabilities
โ Scribed by Ellis, Cynthia R. ;Singh, Nirbhay N. ;Ruane, Amy L.
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 137 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1080-4013
No coin nor oath required. For personal study only.
โฆ Synopsis
Nutritional, dietary, and hormonal approaches to producing behavioral, emotional, and cognitive changes in individuals with mental retardation and developmental disabilities (MRDD) flourished in the 1970s and 1980s. Although an occasional article is still published, there was little serious research activity in recent years until interest in secretin as a potential treatment for autism stimulated the new surge of research currently under way. We briefly discuss the general findings of the effects of various nutritional, dietary, and hormonal approaches in the treatment of individuals with MRDD. We will not review the literature dealing with the nutritional status of individuals with MRDD. We recognize that some of these individuals have disorders that may compromise their nutritional well-being (e.g., maple syrup urine disease, phenylketonuria, and galactosemia) and, therefore, require specific nutritional interventions. Our focus is on nutritional and dietary approaches that are intended to enhance cognitive ability or treat behavioral and emotional problems in individuals with MRDD. We also discuss use of the hormones, melatonin and secretin, in this population. Overall, we found the quality of the research on vitamins, minerals, hormones, and dietary treatments for individuals with MRDD to be overwhelmingly anecdotal and poorly controlled, and the outcomes not strongly supportive of their efficacy.
1999 Wiley-Liss, Inc.
๐ SIMILAR VOLUMES
Treatment for aberrant behavior in persons diagnosed with developmental disabilities typically involves either behavioral interventions or medication. Often, the treatment is a combination of the two. Schroeder and coworkers Adv Learn Behav Disabil 2:179-225) outlined criteria for the evaluation of